4-hydroxy-2-nonenal in mitochondrial DNA damage and contractile dysfunction in diabetic heart: a role for aldehyde dehydrogenase 2
4-羟基-2-壬烯醛在糖尿病心脏线粒体 DNA 损伤和收缩功能障碍中的作用:乙醛脱氢酶 2 的作用
基本信息
- 批准号:9921470
- 负责人:
- 金额:$ 37.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:4 hydroxynonenalAldehydesAmino AcidsAsiansAttenuatedBase Excision RepairsCardiacCardiac MyocytesCardiomyopathiesCardiovascular systemDNADNA DamageDNA RepairDNA Repair EnzymesDataDependovirusDevelopmentDiabetes MellitusDiabetic mouseDrug Metabolic DetoxicationEnzymesExhibitsFunctional disorderGenesGlucoseGoalsGuanineHeartHeart DiseasesHeart MitochondriaHigh Fat DietHyperglycemiaImpairmentIn SituInterventionKnock-inLeadMass Spectrum AnalysisMediatingMitochondriaMitochondrial DNAModelingMusMutant Strains MiceMutationMyocardialMyocardial dysfunctionMyocardiumNon-Insulin-Dependent Diabetes MellitusOxidative StressOxidesPathogenesisPathologyPharmaceutical PreparationsPhysiologicalProteinsReactive Oxygen SpeciesReportingRespirationRespiration DisordersRoleSite-Directed MutagenesisSmall Interfering RNAStreptozocinStressStructureTestingTransfectionType 2 diabeticVariantadductaldehyde dehydrogenasesbasecell injurycovalent bonddiabeticdiabetic cardiomyopathydiabetic patientheart damageheart functionimprovedindexingmacromoleculemolecular modelingmutantnoveloverexpressionpromoterrepair enzymerepairedtherapeutic target
项目摘要
Project Abstract:
Diabetes mellitus (DM) afflicts 26 million people in the US. Around 65% of these diabetic patients die of
cardiovascular complications. We and others have found that DM increases reactive oxygen species (ROS)-
mediated aldehydes like 4-hydroxy-2-nonenal (4HNE) levels. 4HNE forms covalent bonds with macromolecules
known as adducts, which lead to cellular damage and decreased cardiac function. Aldehyde dehydrogenase
(ALDH2) is a cardiac mitochondrial enzyme that detoxifies 4HNE greatly in the heart. We and others have
reported that in streptozotocin-induced hyperglycemic models increase in 4HNE protein adducts and decrease
in myocardial ALDH2 activity correlate with cardiomyopathy. Although we think this causes cardiac dysfunction,
the exact mechanism is unclear. However, most diabetic patients have type-2 DM. Thus, it is imperative to
investigate whether increased mitochondrial 4HNE and lower ALDH2 activity in the cardiomyocytes contribute
to cardiac dysfunction in type-2 DM models. We recently demonstrated that high glucose stress or 4HNE
administration decreased mitochondrial respiration with increased mitochondrial DNA (mtDNA) damage in
cultured cardiomyocytes. In our preliminary study using type-2 diabetic mouse heart, we found an increase in
mitochondrial levels of 8-hydroxyguanine (8OHG), an oxidized mtDNA product, which is primarily repaired by 8-
oxoguanine glycosylase (OGG)-1. Next, we found increased 4HNE adduct formation on OGG-1 and reduced
cardiac OGG-1 levels. These data suggest that 4HNE adduction on OGG-1 reduces its level and activity thereby
raising the unmetabolized 8OHG level. Thus, we postulate that 4HNE-mediated mtDNA damage is part of the
mechanism by which lower ALDH2 causes mitochondrial respiratory dysfunction and thus cardiac contractile
dysfunction. To test our idea, we will use a high-fat diet induced type-2 DM model in wild type C57BL/6 and
ALDH2*2 mutant mice. This mutation mimics East Asians with the E487K variant (ALDH2*2), which exhibits
lower ALDH2 activity. We will overexpress ALDH2 and OGG-1 genes in the myocardium in situ or treat our
diabetic mice with Alda-1, the only specific drug available to improve the catalytic activity of both wild type and
mutant ALDH2. We propose following two specific aims:
Aim 1. To determine whether increased 4HNE adduction on mtOGG-1 causes mtDNA damage, poor
mitochondrial respiration, and impaired cardiomyocyte contractility in type-2 DM.
Aim 2. To determine whether decreasing 4HNE-mediated mtDNA damage after the onset of cardiac
dysfunction in type2-DM attenuates pathogenesis of cardiomyopathy.
This study will identify a novel role of ALDH2 in type-2 DM mediated cardiac dysfunction and establish that
ALDH2 could be a therapeutic target for restoring cardiac function in type-2 diabetic patients.
项目摘要:
糖尿病(DM)困扰着美国2600万人。大约65%的糖尿病患者死于
心血管并发症我们和其他人已经发现,DM增加活性氧(ROS)-
介导的醛类如4-羟基-2-壬烯醛(4 HNE)水平。4 HNE与大分子形成共价键
称为加合物,导致细胞损伤和心脏功能下降。醛脱氢酶
ALDH 2是一种心脏线粒体酶,在心脏中大大解毒4 HNE。我们和其他人已经
报道,在链脲霉素诱导的高血糖模型中,4 HNE蛋白加合物增加,
在心肌中ALDH 2活性与心肌病相关。尽管我们认为这会导致心脏功能障碍,
确切的机制尚不清楚。然而,大多数糖尿病患者患有2型糖尿病。因此,必须
研究心肌细胞中线粒体4 HNE增加和ALDH 2活性降低是否有助于
2型糖尿病模型中的心功能障碍。我们最近证明,高糖应激或4 HNE
给药降低了线粒体呼吸,增加了线粒体DNA(mtDNA)损伤,
培养的心肌细胞在我们对2型糖尿病小鼠心脏的初步研究中,我们发现,
线粒体水平的8-羟基鸟嘌呤(8 OHG),一种氧化的mtDNA产物,主要由8-羟基鸟嘌呤修复。
氧代鸟嘌呤糖基化酶(OGG)-1。接下来,我们发现OGG-1上4 HNE加合物的形成增加,而OGG-1上4 HNE加合物的形成减少。
心脏OGG-1水平。这些数据表明,4 HNE对OGG-1的加合降低了其水平和活性,从而
提高未代谢的8 OHG水平。因此,我们推测4 HNE介导的mtDNA损伤是线粒体损伤的一部分。
ALDH 2降低导致线粒体呼吸功能障碍从而导致心脏收缩的机制
功能障碍为了测试我们的想法,我们将在野生型C57 BL/6中使用高脂肪饮食诱导的2型DM模型,
ALDH 2 *2突变小鼠。这种突变模仿东亚人的E487 K变体(ALDH 2 *2),
ALDH 2活性降低。我们将在心肌原位过表达ALDH 2和OGG-1基因,或者治疗我们的
用Alda-1治疗糖尿病小鼠,Alda-1是唯一可用于改善野生型和
突变ALDH 2。我们提出以下两个具体目标:
目标1.为了确定增加的4 HNE对mtOGG-1的加合是否导致mtDNA损伤,
线粒体呼吸和2型糖尿病心肌细胞收缩力受损。
目标2.为了确定在心脏病发作后减少4 HNE介导的mtDNA损伤是否是一种有效的方法,
2型糖尿病的功能障碍减弱了心肌病的发病机制。
这项研究将确定ALDH 2在2型糖尿病介导的心功能不全中的新作用,并建立
ALDH 2可能是2型糖尿病患者恢复心功能的治疗靶点。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Correction: Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.
校正:2型糖尿病醛脱氢酶2突变小鼠(ALDH 2*2)表现出心力衰竭,具有保留的射血分数表型,可以通过运动应力超声心动图来确定。
- DOI:10.1371/journal.pone.0203581
- 发表时间:2018
- 期刊:
- 影响因子:3.7
- 作者:Pan G;Munukutla S;Kar A;Gardinier J;Thandavarayan RA;Palaniyandi SS
- 通讯作者:Palaniyandi SS
Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography.
- DOI:10.1371/journal.pone.0195796
- 发表时间:2018
- 期刊:
- 影响因子:3.7
- 作者:Pan G;Munukutla S;Kar A;Gardinier J;Thandavarayan RA;Palaniyandi SS
- 通讯作者:Palaniyandi SS
Precision medicine approach: Empagliflozin for diabetic cardiomyopathy in mice with aldehyde dehydrogenase (ALDH) 2 * 2 mutation, a specific genetic mutation in millions of East Asians.
- DOI:10.1016/j.ejphar.2018.09.021
- 发表时间:2018-11-15
- 期刊:
- 影响因子:5
- 作者:Pan G;Deshpande M;Pang H;Palaniyandi SS
- 通讯作者:Palaniyandi SS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Suresh Selvaraj Palaniyandi其他文献
Suresh Selvaraj Palaniyandi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Suresh Selvaraj Palaniyandi', 18)}}的其他基金
Resolvin D1 resolves inflammation in metabolic stress associated HFpEF
Resolvin D1 解决代谢应激相关 HFpEF 中的炎症
- 批准号:
10533087 - 财政年份:2022
- 资助金额:
$ 37.78万 - 项目类别:
Resolvin D1 resolves inflammation in metabolic stress associated HFpEF
Resolvin D1 解决代谢应激相关 HFpEF 中的炎症
- 批准号:
10704156 - 财政年份:2022
- 资助金额:
$ 37.78万 - 项目类别:
4-hydroxy-2-nonenal in mitochondrial DNA damage and contractile dysfunction in diabetic heart: a role for aldehyde dehydrogenase 2
4-羟基-2-壬烯醛在糖尿病心脏线粒体 DNA 损伤和收缩功能障碍中的作用:乙醛脱氢酶 2 的作用
- 批准号:
9756477 - 财政年份:2018
- 资助金额:
$ 37.78万 - 项目类别:
相似海外基金
Replacing Aldehydes in Reductive Amination
在还原胺化中取代醛
- 批准号:
2870985 - 财政年份:2023
- 资助金额:
$ 37.78万 - 项目类别:
Studentship
Free vs bound Strecker aldehydes Impact on chocolate aroma perception
游离与结合的 Strecker 醛对巧克力香气感知的影响
- 批准号:
BB/Y512436/1 - 财政年份:2023
- 资助金额:
$ 37.78万 - 项目类别:
Training Grant
Reactive aldehydes and alcohol misuse in lung infections
肺部感染中的活性醛和酒精滥用
- 批准号:
10581148 - 财政年份:2023
- 资助金额:
$ 37.78万 - 项目类别:
Free vs. bound Strecker aldehydes - Impact on chocolate aroma perception
游离与结合的 Strecker 醛 - 对巧克力香气感知的影响
- 批准号:
2884978 - 财政年份:2023
- 资助金额:
$ 37.78万 - 项目类别:
Studentship
Advancing the Curation of Aldehydes and Ketones for Applications to Cometary Material
推进醛类和酮类在彗星材料中的应用
- 批准号:
563498-2021 - 财政年份:2021
- 资助金额:
$ 37.78万 - 项目类别:
University Undergraduate Student Research Awards
Investigation of the usefulness of aldehydes in exhaled breath gas as prostate cancer biomarkers
研究呼出气体中的醛作为前列腺癌生物标志物的有用性
- 批准号:
21K18089 - 财政年份:2021
- 资助金额:
$ 37.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Aziridine Aldehydes: Novel Reaction Discovery through Amphoterism
氮丙啶醛:通过两性发现新反应
- 批准号:
534459-2019 - 财政年份:2021
- 资助金额:
$ 37.78万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Highly active iron precatalyst for hydrosilylation of ketones and aldehydes using industrially viable silanes - Phase I
使用工业上可行的硅烷进行酮和醛氢化硅烷化的高活性铁预催化剂 - 第一阶段
- 批准号:
566839-2021 - 财政年份:2021
- 资助金额:
$ 37.78万 - 项目类别:
Idea to Innovation
SELF-MASKED ALDEHYDES AS INHIBITORS OF THE CYSTEINE PROTEASES 3CL PROTEASE, CATHEPSIN L, AND CRUZAIN
自掩蔽醛作为半胱氨酸蛋白酶 3CL 蛋白酶、组织蛋白酶 L 和 CruzAIN 的抑制剂
- 批准号:
10355007 - 财政年份:2021
- 资助金额:
$ 37.78万 - 项目类别:
Understanding the molecular pathways that underpin production, sensing and protection against aldehydes
了解支持醛类产生、传感和防护的分子途径
- 批准号:
2595805 - 财政年份:2021
- 资助金额:
$ 37.78万 - 项目类别:
Studentship














{{item.name}}会员




